reviewClinical PharmacokineticsJan 1, 2005Closed access

Clinical Pharmacokinetics of Imatinib

BPBin PengPLPeter LloydHSHorst Schran

Novartis (Switzerland) · Novartis (United States) · +1 more institution

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

660
total citations
FWCI
11.68
Percentile
100%
References
73
Citations per year

Authors

3

Topics & keywords

Topics
Keywords
  • Imatinib
  • Pharmacokinetics
  • Pharmacology
  • Tyrosine-kinase inhibitor
  • Tyrosine kinase
  • Medicine
  • Bioavailability
  • Oral administration
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.